Papers in Skin Health and Disease
Page 1 · newest first
- Assessing the content validity of the 2015 core domain set for vitiligo clinical trials: preliminary investigations for developing an updated versionSkin Health and Disease · 2026
- A fluorescence-based reporter system to monitor human papillomavirus E2-dependent reporter activation in keratinocytesSkin Health and Disease · 2026
- Association of red cell distribution width with disease activity and antidesmoglein antibody levels in pemphigus vulgaris: a prospective case–control studySkin Health and Disease · 2026
- Mismatch repair protein deficiency in sebaceous neoplasms and its associations: a two-centre retrospective analysis in IranSkin Health and Disease · 2026
- Neurological adverse events of ivermectin: a retrospective pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) databaseSkin Health and Disease · 2026
- Pilomatrixomas: syndromic associations and a guide to germline genetic testingSkin Health and Disease · 2026
- Does avoidance of oral exposure to patch test allergens benefit patients with eczema? A systematic reviewSkin Health and Disease · 2026
- Eosinophils and eosinophilic skin diseases: a narrative reviewSkin Health and Disease · 2026
- Beyond the surface: pseudoxanthoma elasticum in skin of colourSkin Health and Disease · 2026
- A case of verrucous venous malformation and challenges associated with treatmentSkin Health and Disease · 2026
- Polymorphous immunotherapy-induced cutaneous sarcoidosisSkin Health and Disease · 2026
- A systematic review of the clearance and recurrence rate of recalcitrant warts following bleomycin treatmentSkin Health and Disease · 2026
- Inequality and determinants of access to phototherapy among patients with psoriasis in ThailandSkin Health and Disease · 2026
- Machine learning applications in androgenetic alopecia: a systematic reviewSkin Health and Disease · 2026
- Prevalence and determinants of anxiety and depression in adult patients with atopic dermatitis in TanzaniaSkin Health and Disease · 2026
- Anti-Ro52-positive antisynthetase syndrome mimicking tuberculosis in a high-burden setting: a delayed diagnosis with therapeutic successSkin Health and Disease · 2026
- Beyond diagnostic accuracy: evaluating the clinical utility of artificial intelligence for suspicious lesion triageSkin Health and Disease · 2026
- Rapidly growing well-differentiated cutaneous squamous cell carcinoma of the scalp in a patient who was immunosuppressedSkin Health and Disease · 2026
- Improving undergraduate teaching of chronic wounds with three-dimensional silicone models: a Finnish questionnaire-based cohort studySkin Health and Disease · 2026
- A single-centre, retrospective cohort study of paediatric tinea capitis in the United KingdomSkin Health and Disease · 2026
- Efficacy and safety of two interleukin-17 inhibitors (bimekizumab and secukinumab) in the management of hidradenitis suppurativa: a systematic review and meta-analysis of randomized controlled trialsSkin Health and Disease · 2026
- Guselkumab as a therapeutic option for recalcitrant pyoderma gangrenosum and Crohn disease: a case report and review of the literatureSkin Health and Disease · 2026
- Efficacy and safety of spesolimab in resistant pyoderma gangrenosum: a case report and brief review of the literatureSkin Health and Disease · 2026
- Racial and ethnic disparities in T helper 2-mediated inflammatory skin disordersSkin Health and Disease · 2026
- ‘My HS is significantly impacted by my cycle’: a cross-sectional study exploring the impact of menstruation and pregnancy on hidradenitis suppurativaSkin Health and Disease · 2026
- Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonistsSkin Health and Disease · 2026
- A case of bilateral upper limb eczema herpeticumSkin Health and Disease · 2026
- Clinical trial exit interviews in patients with moderate-to-severe chronic hand eczema: perspectives on disease burden and treatment experiences with delgocitinib cream in the phase III DELTA 1 trialSkin Health and Disease · 2026
- Identifying and addressing obstacles to optimal alopecia areata and atopic dermatitis care in the UKSkin Health and Disease · 2026
- Evaluating serum procollagen type III N-terminal peptide use as a liver fibrosis screening test in patients with psoriasis receiving methotrexate: a retrospective service evaluation in comparison with the Fibrosis-4 (FIB-4) indexSkin Health and Disease · 2026
- Atypical Spitz tumours across age groups: clinicopathological features, management strategies and long-term outcomes in a 20-year retrospective cohort studySkin Health and Disease · 2026
- Enhanced in vivo thromboxane biosynthesis in melanoma compared with basal cell carcinoma skin cancersSkin Health and Disease · 2026
- Performance of the ‘DermDx’ algorithm in triaging suspected skin cancers: results of the AI-SCSS studySkin Health and Disease · 2026
- Socioeconomic factors and time to diagnosis in hidradenitis suppurativaSkin Health and Disease · 2026
- Progressive isolated lower-lip oedema after mRNA COVID-19 booster complicated by methicillin-resistant Staphylococcus aureus superinfection: a necrotizing fasciitis mimicSkin Health and Disease · 2026
- Comparison of narrowband ultraviolet B with psoralen plus ultraviolet A phototherapy for patients with early-stage mycosis fungoides: a systematic review and meta-analysisSkin Health and Disease · 2026
- Guselkumab treatment of psoriasis results in sustained reduction of systemic inflammatory biomarkers to week 48 in three phase III randomized controlled trialsSkin Health and Disease · 2026
- Healthcare resource use, costs and health-related quality of life in the UK–Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot studySkin Health and Disease · 2026
- Immunological aspects and quality of life among patients with lichen sclerosusSkin Health and Disease · 2026
- A survey of topical treatment adherence and self-compassion in people living with psoriasisSkin Health and Disease · 2026
- A new association of cutaneous leishmaniasis with guselkumab in a patient with chronic psoriasisSkin Health and Disease · 2026
- Psychodermatology in Ireland: current practices, confidence and barriers among dermatologistsSkin Health and Disease · 2026
- Factors associated with prolonged hospital stay in patients with autoimmune bullous diseases treated at an in-patient dermatology serviceSkin Health and Disease · 2026
- A middle-aged man with progressive facial swelling and generalized violaceous plaquesSkin Health and Disease · 2026
- Living with cutaneous porphyria: findings from a qualitative survey studySkin Health and Disease · 2026
- Efficacy and safety of topical statins for porokeratosis: a systematic review and practice-guided synthesisSkin Health and Disease · 2026
- Living with melanoma: a study protocol for the design and participatory development of a survivorship care programme for people with metastatic melanomaSkin Health and Disease · 2026
- Skin cancer prevention practices of barbers for their customers: a pilot studySkin Health and Disease · 2026
- Narrowband ultraviolet B and psoralen plus ultraviolet A phototherapy treatment for mycosis fungoides: a 17-year retrospective cohort study in a university teaching hospital, 2007–24Skin Health and Disease · 2026
- ALADIN (Acne Lesion And Density INdex): a novel tool for automatic acne severity assessmentSkin Health and Disease · 2026